At Live Well Weight Loss, many patients have started their journey with Mounjaro® (tirzepatide). However, due to changes in supply and pricing, some people may now be considering or needing to switch to Wegovy® (semaglutide).
We want to reassure you that any switch will be handled carefully and on a case-by-case basis, with your safety and results as our top priority.
Why Might You Switch?
Mounjaro is an effective treatment for weight loss, but with current supply challenges, some patients may find it difficult to continue. Wegovy is now more widely available in the UK and provides another clinically proven option.
Key Differences Between Mounjaro and Wegovy
Mounjaro (tirzepatide): Works on two appetite and blood sugar pathways (GLP-1 and GIP).
Wegovy (semaglutide): Works on a single pathway (GLP-1), but still has strong evidence for long-term weight loss.
Both are weekly injections designed to support sustainable weight loss.
What to Expect if You Switch
If you are moving from Mounjaro to Wegovy, we will:
Review your medical history and current progress
Recommend the most appropriate starting dose of Wegovy
Monitor your response closely and adjust treatment as needed
This process will always be tailored to your individual needs.
Wegovy Pricing at Live Well Weight Loss
We believe in keeping pricing simple and transparent:
0.25 mg – £109
0.5 mg – £109
1 mg – £109
1.7 mg – £159
2.4 mg – £210
Support Every Step of the Way
Switching treatments can feel like a big step, but you won’t be alone. At Live Well Weight Loss, we provide:
Personalised consultations with our pharmacist prescribers
Clear guidance on side effects and dose adjustments
Regular follow-ups to track your progress
A safe, UK-regulated service you can trust
Final Thoughts
Both Mounjaro and Wegovy are highly effective treatments for weight management. If you are currently on Mounjaro and may need to switch to Wegovy, we will assess your case individually and guide you through the transition.
